Clinical outcomes following bilateral implantation of two different trifocal hydrophobic diffractive intraocular lenses

Clinical outcomes following bilateral implantation of two different trifocal hydrophobic diffractive intraocular lenses - PANFINE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034576

Enrollment

156

Registered

2025-02-27

Start date

2024-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyes operated by cararact surgery

Interventions

Group 1: All patients participating in the study will be bilaterally implanted with the Clareon PanOptix intraocular lens (IOL) (non-toric CNWTT0 or toric CNWTT) from Alcon with CE marking or the Fine

Eligibility

Sex/Gender

All

Age

40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who will undergo cataract surgery (grade 3 LOCS III) and who are candidates for bilateral implantation of the Clareon PanOptix IOL or the FineVision HP IOL (toric or non-toric). 2. Age between 40 and 85 years old. 3. Able to understand and willing to sign informed consent and complete all required postoperative follow-up procedures. 4. Expected postoperative refractive refractive astigmatism of =0.50D. Patients agree to undergo a second eye surgery between 2 days and 1 month after the first eye surgery.

Exclusion criteria

Exclusion criteria: 1. Glaucoma, retinal or corneal disease. 2. Prior corneal or intraocular surgery or trauma. 3. Any anterior segment pathology such as chronic uveitis, iritis or corneal dystrophy that may significantly affect the results. 4. IOLs with low toricity (Clareon PanOptix Toric T2 or FineVision FT 49P 1.0).

Design outcomes

Primary

Measure	Time frame
The primary outcome variable for this study is distance-corrected intermediate binocular visual acuity (DCIVA).	—

Secondary

Measure	Time frame
Equivalent spherical error will also be studied, as well as visual acuity at far, intermediate (80 cm) and near (40 cm) distances (with and without distance correction), slit lamp examination and defocus curve. Pre- and post-surgery changes will be analyzed in order to know the changes in refraction, vision and patient satisfaction questionnaires after IOL implantation. In addition, two satisfaction questionnaires will be completed and demographic data will be recorded.	—

Measure

Time frame

Equivalent spherical error will also be studied, as well as visual acuity at far, intermediate (80 cm) and near (40 cm) distances (with and without distance correction), slit lamp examination and defocus curve. Pre- and post-surgery changes will be analyzed in order to know the changes in refraction, vision and patient satisfaction questionnaires after IOL implantation. In addition, two satisfaction questionnaires will be completed and demographic data will be recorded.

—

Countries

Spain

Contacts

Public ContactMaría Cobo

OFTALVIST

maria.cobo@oftalvist.es+34 963513304

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026